Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
Authors:
Open Access
- 27 February 2019
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 7 (5) , e623
Abstract
Background: Congenital adrenal hyperplasia (CAH) (OMIM #201910) is a complex disease most often caused by pathogenic variant of the CYP21A2 gene. We have designed an efficient multistep approach to diagnose and classify CAH cases due to CYP21A2 variant and to study the genotype‐phenotype relationship.Methods: A large cohort of 212 Vietnamese patients from 204 families was recruited. We utilized Multiplex Ligation‐dependent Probe Amplification to identify large deletion or rearrangement followed by complete gene sequencing of CYP21A2 to map single‐nucleotide changes and possible novel variants.Results: Pathogenic variants were identified in 398 out of 408 alleles (97.5%). The variants indexed span across most of the CYP21A2 gene regions. The most common genotypes were: I2g/I2g (15.35%); Del/Del (14.4%); Del/I2g (10.89%); p.R356W/p.R356W (6.44%); and exon 1–3 del/exon 1–3 del (5.44%). In addition to the previously characterized and documented variants, we also discovered six novel variants which were not previously reported, in silico tools were used to support the pathogenicity of these variants.Conclusion: The result will contribute in further understanding the genotype‐phenotype relationship of CAH patients and to guide better treatment and management of the affected.Keywords
Funding Information
- Ministry of Health (908/QD-BYT)
This publication has 31 references indexed in Scilit:
- Steroid 21‐hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype–phenotype correlation in a large cohort of patients with congenital adrenal hyperplasiaClinical Endocrinology, 2011
- Congenital adrenal hyperplasia: an update in childrenCurrent Opinion in Endocrinology, Diabetes and Obesity, 2011
- Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2010
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- A novel 9-bp insertion detected in steroid 21-hydroxylase gene (CYP21A2): prediction of its structural and functional implications by computational methodsJournal of Biomedical Science, 2009
- 21-Hydroxylase Genotyping in Australasian Patients with Congenital Adrenal HyperplasiaJournal of Pediatric Endocrinology and Metabolism, 2009
- Three Novel Mutations in Japanese Patients with 21-Hydroxylase DeficiencyHormone Research in Paediatrics, 2004
- Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyEndocrine Reviews, 2000
- Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiencyJournal of Human Genetics, 1999
- Population-Wide Evaluation of Disease Manifestation in Relation to Molecular Genotype in Steroid 21-Hydroxylase (CYP21) Deficiency: Good Correlation in a Well Defined PopulationThe Journal of Clinical Endocrinology & Metabolism, 1997